Regencell Bioscience Holdings Ltd (RGC NASDAQ) stock market data APIs
$28.8218
0.62(2.2%)
as of April 8, 2026
Try our APIs with
free plan!
Regencell Bioscience Holdings Ltd Financial Data Overview
Price chart is built with
Anychart
Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
Prev. Close
28.8218
Open
29.4382
High
30.3696
Low
28.2136
52 wk Range
0.7033-83.6
Market Cap
13 776 M
Shares Outstanding
494 M
EPS
0
Beta
2.247
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Regencell Bioscience Holdings Ltd data using free add-ons & libraries
Get Regencell Bioscience Holdings Ltd Fundamental Data
Regencell Bioscience Holdings Ltd Fundamental data includes:
- Net Revenue:
- EBITDA: -3 692 293
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-18
- EPS/Forecast: 0
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Regencell Bioscience Holdings Ltd News
New
Here's Why I Wouldn't Touch Regencell Bioscience With a 10‑Foot Pole Right Now
Key Points Regencell Bioscience is an early-stage bioscience company that has been working since 2014 to develop a marketable drug. The company's focus area is traditional Chinese medicine.10 stocks ...
Here's Why I Wouldn't Touch Regencell Bioscience With a 10‑Foot Pole Right Now
Regencell Bioscience(NASDAQ: RGC) has a surprisingly large market cap of nearly $12 billion. The stock is up a shocking 21,000% over the past year. It started the 52-week period as a penny stock. Inve...
Don't Even Think About Buying Regencell Bioscience Stock Until You See This 1 Red Flag
Regencell Bioscience(NASDAQ: RGC) is an early-stage bioscience company. That alone should be enough to keep most investors on the sidelines, given the risks involved if the medicines the company is wo...
Bragar Eagel & Squire, P.C. Continues Investigations into Regencell and Camping World on Behalf of Stockholders and Encourages Investors to Contact the Firm
NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Regencell Bioscience Holdings...
Get Regencell Bioscience Holdings Ltd fresh news feed via Financial News API
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
